Shrimpex Biotech Services Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 23-12-2024
- Paid Up Capital ₹ 1.46 Cr
as on 23-12-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.10 Cr
as on 23-12-2024
- Revenue 3.86%
(FY 2022)
- Profit 67.33%
(FY 2022)
- Ebitda -42.70%
(FY 2022)
- Net Worth 1.83%
(FY 2022)
- Total Assets -22.38%
(FY 2022)
About Shrimpex Biotech Services
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 1.46 Cr.
The company currently has active open charges totaling ₹7.10 Cr.
Soosai Thatheus and Michael Rozario serve as directors at the Company.
- CIN/LLPIN
U05004TN2011PTC080702
- Company No.
080702
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Shrimpex Biotech Services Private Limited offer?
Shrimpex Biotech Services Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit, Pathology Lab Equipments, Material Testing Labs & Services, Food testing services, Diagnostic Imaging & Pathology Labs, Medical Test Services.
Who are the key members and board of directors at Shrimpex Biotech Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Soosai Thatheus  | Director | 19-May-2011 | Current |
| Michael Rozario | Director | 28-Feb-2020 | Current |
Financial Performance of Shrimpex Biotech Services.
Shrimpex Biotech Services Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.86% increase. The company also saw a substantial improvement in profitability, with a 67.33% increase in profit. The company's net worth moved up by a moderate rise of 1.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shrimpex Biotech Services?
In 2022, Shrimpex Biotech Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 09 Sep 2015 | ₹5.00 Cr | Open |
Indian Bank Creation Date: 29 Sep 2011 | ₹2.10 Cr | Open |
How Many Employees Work at Shrimpex Biotech Services?
Shrimpex Biotech Services has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shrimpex Biotech Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shrimpex Biotech Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
